Arginine-conjugated polypropylenimine dendrimer as a non-toxic and efficient gene delivery carrier

被引:133
作者
Kim, Tae-il [1 ]
Baek, Jung-un [1 ]
Bai, Cheng Zhe [1 ]
Park, Jong-sang [1 ]
机构
[1] Seoul Natl Univ, Sch Chem & Mol Engn, Seoul 151742, South Korea
关键词
gene delivery; polypropylenimine dendrimer; arginine-conjugation; low cytotoxicity; high transfection;
D O I
10.1016/j.biomaterials.2006.12.013
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
We synthesized arginine-conjugated polypropylenimine dendrimer G2 (DAB-8), PPI2-R for gene delivery systems. Synthesized PPI2R could retard plasmid DNA at a weight ratio of 4 completely and PPI2-R polyplexes showed a fluorescence of less than 10% over a charge ratio of 2 by PicoGreen reagent assay, suggesting its good DNA condensing ability. The size of PPI2-R polyplex was measured to about 200 nm at a charge ratio of 150. PPI2-R displayed 80-90% cell viability at even a 150 mu g/mL concentration. Transfection efficiency of PPI2-R was found to be high comparable to that of PEI25kD and to be 8-214 times higher than that of unmodified PPI2 on HeLa and 293 cells. Moreover, PPI2-R showed 4 times higher transfection efficiency than PE125kD, treating with 10 mu g pDNA because of its low cytotoxicity on HeLa cells. Finally, PPI2-R showed a transfection efficiency 2-3 times higher than PE125kD on HUVECs, showing its potency as a gene delivery carrier for primary cells. These results demonstrate that arginine-conjugation of PPI2 is successful in developing a low toxic and highly transfection efficient gene delivery carrier. (c) 2006 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2061 / 2067
页数:7
相关论文
共 27 条
[21]   Commentary - Dendrimers in biomedical applications - reflections on the field [J].
Svenson, S ;
Tomalia, DA .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (15) :2106-2129
[22]   DNA nanoparticles and development of DNA delivery vehicles for gene therapy [J].
Vijayanathan, V ;
Thomas, T ;
Thomas, TJ .
BIOCHEMISTRY, 2002, 41 (48) :14085-14094
[23]   Improvement of gene delivery mediated by mannosylated dendrimer/α-cyclodextrin conjugates [J].
Wada, K ;
Arima, H ;
Tsutsumi, T ;
Chihara, Y ;
Hattori, K ;
Hirayama, F ;
Uekama, K .
JOURNAL OF CONTROLLED RELEASE, 2005, 104 (02) :397-413
[24]   Transmembrane delivery of protein and peptide drugs by TAT-mediated transduction in the treatment of cancer [J].
Wadia, JS ;
Dowdy, SF .
ADVANCED DRUG DELIVERY REVIEWS, 2005, 57 (04) :579-596
[25]   Polylysine-based transfection systems utilizing receptor-mediated delivery [J].
Zauner, W ;
Ogris, M ;
Wagner, E .
ADVANCED DRUG DELIVERY REVIEWS, 1998, 30 (1-3) :97-113
[26]   Intracellular cargo delivery using tat peptide and derivatives [J].
Zhao, M ;
Weissleder, R .
MEDICINAL RESEARCH REVIEWS, 2004, 24 (01) :1-12
[27]   The lower-generation polypropylenimine dendrimers are effective gene-transfer agents [J].
Zinselmeyer, BH ;
Mackay, SP ;
Schatzlein, AG ;
Uchegbu, IF .
PHARMACEUTICAL RESEARCH, 2002, 19 (07) :960-967